H. W. Klafki, P. A. Paganetti, B. Sommer and M. Staufenbiel, “Calpain Inhibitor I Decreases Beta A4 Secretion from Human Embryonal Kidney Cells Expressing Beta-Amyloid Precursor Protein Carrying the APP670/ 671 Double Mutation,” Neuroscience Letters, Vol. 201, No. 1, 1995, pp. 29-32. doi:10.1016/0304-3940(95)12122-K

has been cited by the following article:

• TITLE: The Functions of the Amyloid Precursor Protein Gene and Its Derivative Peptides: III Pharmacological Studies

  AUTHORS: Peter K. Panegyres, Emily R. Atkins

  KEYWORDS: Amyloid Precursor Protein, APP, Genes, Dementia, Alzheimer’s Disease

  JOURNAL NAME: Neuroscience and Medicine, Vol.2 No.4, December 2, 2011

  ABSTRACT: Pharmacological studies reveal APP and Aβ have interactions with glutamate and calcium, cytokines, copper/zinc chelators, secretases and presenilins, nicotinic receptors, acetycholinesterase, neurotrophins, non-steroidal anti-inflame-matory drugs, monoclonal antibodies to Aβ, protease inhibitors, oestrogen, homocysteine, immediate early genes such as c-fos or c-jun and cholesterol. These functional and pharmacological observations highlight the need for greater understanding of APP and Aβ in brain function and have implications for clinical trials.